Skadden Strives To Tame Flames In Endo's Opioid Imbroglio
By Jeff Overley · October 26, 2021, 10:14 PM EDT
Scorched by cover-up claims in nationwide opioid litigation, Endo Pharmaceuticals is hoping for heroics from a Skadden squad that is belatedly revealing vast volumes of drug marketing records, a strategy that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login